BioTech/Drugs - Plymouth Meeting, PA, US
PsiOxus aims to be the world's leading company in tumour re-programming, delivering medicines of value to patients with cancer.PsiOxus is a clinical stage oncology company pioneering systemic immune oncology products that drive sustained reprogramming of the tumor microenvironment to overcome the central challenge of resistance to therapy. Our validated T-SIGn® vector platform can deliver multiple transgene payloads that re-program both primary and metastatic tumors. We have a rapidly expanding pipeline of novel monotherapy and combination products to dramatically improve outcomes for patients with cancer.Find our more about us at www.psioxus.com
Outlook
Cloudflare DNS
CloudFlare Hosting
Google Analytics
Google Maps